Clinical Trial Update: A Clinical Study to Compare Combination of Aliskiren+ HCTZ to Irbesartan+ HCTZ or Amlodipine+ HCTZ or HCTZ Alone in Obese Hypertensive Not Responsive to HCTZ 25 mg [Phase 3]

View source ↗

Summary

Phase 3 trial comparing aliskiren+HCTZ with irbesartan+HCTZ, amlodipine+HCTZ, or HCTZ alone in obese hypertensive patients not responsive to HCTZ 25 mg; the stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Aliskiren (Aliskiren)
• Amlodipine (amlodipine)
• HYDROCHLOROTHIAZIDE (hydrochlorothiazide)
• Irbesartan (irbesartan)

Snippet

Sponsor: Novartis | Conditions: Hypertension | Phase 3 | Status: COMPLETED